Skip to main content

Rhinocerebral Mucormycosis

  • Chapter
  • 186 Accesses

Abstract

Rhinocerebral mucormycosis is an uncommon, but rapidly progressive, fungal infection of the nose and sinuses that plagues diabetics and other immunocompromised patients. Its invasion results in fulminating disease that often runs its course within days. The organisms are inhaled and deposited in the nasal and pharyngeal mucosa. In the appropriate host, invasion occurs rapidly, leading to involvement of the paranasal sinuses with subsequent spread into the orbit and cranial cavity. Mucormycosis is the most acutely fatal fungal infection known (1). Survival depends on prompt diagnosis and the aggressive institution of appropriate therapies (1, 2). A diagnosis of mucormycosis must be suspected in immunocompromised patients presenting with sinusitis, especially if there has been a slow or minimal clinical response to antibiotics.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Eisenberg L, Wood T, Boles R. Mucormycosis. Laryngoscope 1977;87:347–356.

    Article  PubMed  CAS  Google Scholar 

  2. Lehrer RI, Howard DH, Sypherd PS, Edwards JE, Segal GP, Winston DJ. Mucormycosis. Ann Int Med 1980;93(l):93–108.

    Google Scholar 

  3. Sugar AM. Mucormycosis. Clin Infectious Diseases 1992;14(Suppl. 1):S126–S129.

    Article  Google Scholar 

  4. Terk MR, Underwood DJ, Zee CS, Colletti PM. MR imaging in rhinocerebral and intracranial mucormycosis with CT and pathologic correlation. Magn Reson Imaging 1992; 10:81–87.

    Article  PubMed  CAS  Google Scholar 

  5. Fisher EW, Toma A, Fisher PH, Cheesman AD. Rhinocerebral mucormycosis: use of liposomal amphotericin B. J Laryngol Otol 1991;105:575–577.

    Article  PubMed  CAS  Google Scholar 

  6. Ferguson BJ, Mitchell TG, Moon R, Camporesi EM, Farmer J. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infectious Diseases 1988;10(3):551–559.

    Article  CAS  Google Scholar 

  7. Nussbaum ES, Hall WA. Rhinocerebral mucormycosis: changing patterns of disease. SurgNeurol 1994; 1:152–156.

    Google Scholar 

  8. Sponsler TA, Sassani JW, Johnson LN, Towfighi J. Ocular invasion in mucormycosis: survey of ophthalmology. 1992;36(5):345–350.

    PubMed  CAS  Google Scholar 

  9. Kemper J, Kuijper EJ, Mirck PGB, Balm AJM. Recovery from rhinocerebral mucormycosis in a ketoacidotic diabetic patient: a case report. J Laryngol Otol 1993; 107:233–235.

    Article  PubMed  CAS  Google Scholar 

  10. Anand VK, Alemar G, Griswold JA. Intracranial complications of mucormycosis: an experimental model and clinical review. Laryngoscope 1992; 102:656–662.

    Article  PubMed  CAS  Google Scholar 

  11. Blitzer A, Lawson W, Meyers BR, Biller HF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 1980;90:635–648.

    Article  PubMed  CAS  Google Scholar 

  12. Couch L, Theilen F, Mader JT. Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy. Arch Otolaryngol Head and Neck Surg 1988; 114:791–794.

    Article  CAS  Google Scholar 

  13. Ziegler EI Cerebral mucormycosis; neurologic infections. In: Braude AJ, ed., Medical Microbiology and Infectious Diseases. Philadelphia, PA: W. B. Saunders, 1985, pp. 1085–1088.

    Google Scholar 

  14. De La Paz MA, Patrinely JR, Marines HM, Appling WD. Adjunctive hyperbaric oxygen in the treatment of bilateral cerebro-rhino-orbital mucormycosis. Am J Ophthalmology 1992; 114:208–211.

    Google Scholar 

  15. Abedi E, Sismanis A, Choi K, Pastore P. Twenty-five years’ experience treating cerebro-rhino-orbital mucormycosis. Laryngoscope 1984;94:1060–1062.

    PubMed  CAS  Google Scholar 

  16. Estrem SA, Tully R, Davis WE. Rhinocerebral mucormycosis: computed tomographic imaging of cavernous sinus thrombosis. Ann Otol Rhinol Laryngol 1990; 99:160,161.

    PubMed  CAS  Google Scholar 

  17. Gamba JL, Woodruff WW, Djang WT, Yeates AE. Craniofacial mucormycosis: assessment with CT. Radiology 1986;160(l):207–212.

    PubMed  CAS  Google Scholar 

  18. LePage E. Using a ventricular reservoir to instill amphotericin B. JNeurosci Nursing 1993;25(4):212–217.

    Article  CAS  Google Scholar 

  19. Gass JDM. Acute orbital mucormycosis. Report of two cases. Arch Ophthal 1961;65:214–221.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kendall, K.A., Senders, C.W. (1996). Rhinocerebral Mucormycosis. In: Gershwin, M.E., Incaudo, G.A. (eds) Diseases of the Sinuses. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0225-7_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-0225-7_17

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4612-6670-9

  • Online ISBN: 978-1-4612-0225-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics